[Federal Register Volume 75, Number 202 (Wednesday, October 20, 2010)]
[Notices]
[Pages 64736-64737]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-26400]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0001]
Request for Nominations for Voting Members on a Public Advisory
Committee; Science Board to the Food and Drug Administration
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting
nominations for voting members to serve on the Science Board to FDA,
Office of the Commissioner, Office of Chief Scientist.
FDA has a special interest in ensuring that women, minority groups,
and individuals with disabilities are adequately represented on
advisory
[[Page 64737]]
committees and, therefore, encourages nominations of qualified
candidates from these groups.
DATES: Nominations received by November 19, 2010, will be given first
consideration for membership on the Science Board. Nominations received
after November 19, 2010, will be considered for nomination to the
committee should nominees still be needed.
ADDRESSES: All nominations for membership should be sent electronically
to [email protected], or by mail to Advisory Committee Oversight and
Management Staff, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, Silver
Spring, MD 20993-0002. Information about becoming a member on an FDA
advisory committee can also be obtained by visiting FDA's Web site at
http://www.fda.gov/oc/advisory/default.htm.
FOR FURTHER INFORMATION CONTACT: Regarding all nomination questions for
membership: Donna L. Mentch, Office of the Commissioner, Food and Drug
Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 4203, Silver
Spring, MD 20993-0002, 301-796-8523, FAX: 301-847-8617,
[email protected].
SUPPLEMENTARY INFORMATION: FDA is requesting nominations for voting
members on the Science Board to FDA.
I. General Function of the Committee
The Science Board shall provide advice primarily to the
Commissioner of FDA (the Commissioner) and other appropriate officials
on specific complex and technical issues as well as emerging issues
within the scientific community. Additionally, the Science Board will
provide advice to the Agency on keeping pace with technical and
scientific evolutions in the fields of regulatory science, on
formulating an appropriate research agenda, and on upgrading its
scientific and research facilities to keep pace with these changes. It
will also provide the means for critical review of Agency sponsored
intramural and extramural scientific research programs.
II. Criteria for Voting Members
FDA is requesting nominations of voting members with appropriate
expertise in the following fields of food safety, nutrition, chemistry,
pharmacology, toxicology, clinical research, epidemiology, product
safety, product manufacturing sciences and quality or other scientific
areas relevant to FDA regulated products such as systems biology,
bioinformatics, wireless health care devices, nanotechnology, and
combination products. Members shall be chosen from academia and
industry. The Science Board may include one technically qualified
member, selected by the Commissioner or designee, who is identified
with consumer interests and is recommended by either a consortium of
consumer-oriented organizations or other interested persons. The
Science Board may also include technically qualified Federal members.
III. Nomination Procedures
Any interested person may nominate one or more qualified persons
for membership on the Science Board. Self-nominations are also
accepted. Nominations must include a current, complete resume or
curriculum vitae for each nominee, current business and/or home
address, telephone number, and email address if available. Nominations
must specify the advisory committee for which the nominee is
recommended. Nominations must also acknowledge that the nominee is
aware of the nomination, unless self-nominated. FDA will ask potential
candidates to provide detailed information concerning such matters as
financial holdings, employment, and research grants and/or contracts.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14 relating to advisory committees.
Dated: October 15, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-26400 Filed 10-19-10; 8:45 am]
BILLING CODE 4160-01-P